Mounjaro KwikPen Launch

Objectives

• Patients With T2D Are Not Achieving HbA1c Targets, While Their BMIs Are Increasing
• Excess Weight Is a Key Component of T2D Pathophysiology
• Achieving and Maintaining Weight Loss Is Challenging for Patients With T2D
• Addressing Excess Weight Can Support Better Management of T2D and
Reduction of T2D-Related Complications
• Patients With T2D Need Better and Earlier Glycemic Interventions and
Weight-Loss Support

This Course For :

Physician ( Endocrinology & Metabolism , Family Medicine , Internal Medicine , General Practitioners )
Resident / Fellow ( Endocrinology & Metabolism , Family Medicine , Internal Medicine , General Practitioners )
Clinical Pharmacy
Pharmacy

Speaker

Provided by :

Price

Course Fee

FREE

FREE
See Registration Policies, Cancellations & Refunds

Contact Information

Organization : Virtual Medical Academy
Phone : 920008161
Email : [email protected]

  • 01 Oct 2024    To    01 Oct 2024
  • 09:00 PM  To  11:00 PM
  • Certificate Available
  • Online Click Here
  • 362
  Add to Calendar 10/01/2024 09:00 PM 10/01/2024 11:00 PM Asia/ Riyadh Mounjaro KwikPen Launch Mounjaro KwikPen Launch https://medicalacademy.org/portal/event/view/2257
Mounjaro KwikPen Launch